Aktiesnakken — Juli 2012
-
men min research syncs bare at de er mere life science end vandrensende?
-
record revenues of $16.1 billion with core revenue growth of 7%.
r&D spending exceeded $1 billion for the first time in Danaher’s history.
Free cash flow of $2.4 billion with a free cash flow to net income conversion ratio of 124%, representing the 20th consecutive year in which free cash flow exceeded net income.
Deployed a record $7.5 billion of capital to acquire 14 new companies, including Beckman Coulter, across all five operating segments. -
det var så Danaher. som ganske rigtigt har noget vand rensende under opsejling
-
Hvad kom Fortum ud med?
-
de har stadigt tjent 0,77 euro ytd
-
ja yielden fejler ikke noget
-
det er en af de virksomheder jeg gerne ville have flere aktier i
-
men de har lånt til dividenden......
-
det gjorde mig en smule mindre entusiastisk
-
hvis den historie passer er der ved at komme fart på vareflow http://borsen.dk/nyheder/virksomheder/artikel/1/237281/maersk_indgaar_stor_skibslejeaftale.html
-
ja det kunne måske godt være
-
læg iøvrigt mærke til at schouw er begyndt at gå op sammen med vestas
-
den taber en hel euro på det regnskab. Øv.
-
jeg tror jeg vil have flere
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind